UC San Diego Health Sciences schools, institutes and centers are at the forefront of discovery and transformation.
Twenty-two University of California, San Diego scientists and physicians are among the 2015 listing of “The World’s Most Influential Scientific Minds,” an annual compendium of “Highly Cited Researchers” by Thomson Reuters, a multinational mass media and information company.
Researchers at the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego have entered into a research collaboration with Janssen Research & Development, LLC (Janssen R&D), one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to identify new therapeutic targets for Chagas disease, a parasitic infection that is the leading cause of heart failure in Latin America.
A team of researchers, with the aid of the Gordon supercomputer at the San Diego Supercomputer Center based at UC San Diego, has identified a class of possible antibiotics with the potential to disable previously drug-resistant bacteria.
The renewed emphasis on strengthening the university’s “innovation ecosystem” gets a big boost this week with the launch of the UC San Diego Entrepreneurs-in-Residence program.
UC San Diego Launches CORE A set of best practices will guide Institutional Review Boards (IRBs) and researchers in the design and review of studies that use social media, self-tracking devices and other mobile technologies.to Foster Ethical Research Using Personal Health Data
The recently formed Office of Innovation & Commercialization (OIC), a division of the Office of Research Affairs, is announcing the Open-Flow Innovation program, a new business-friendly approach to rapidly license technologies to new start-up companies.
Forbes, May 29
San Diego Union Tribune, May 28
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
